We hope to see you again soon!

You are now leaving Lundbeck UK's website (www.lundbeck.com/uk) for an external website. External links are provided as a resource to the viewer. Lundbeck UK are not responsible for the external website and its content.

UK-NOTPR-1010 | April 2022



Research & Development

Lundbeck – A Premier Neuroscience Company

Our Research & Development (R&D) organisation is guided by our ambition to become number one in brain health. 

R&D’s contribution to the Lundbeck value chain is as innovators, discovering and developing new therapies to treat neurology and psychiatry indications with high unmet medical needs.


R&D has a truly global footprint, employing over 700 talented colleagues within facilities in Denmark, the US, China, Japan, and Singapore.


Our global functions include Research, Non-clinical Research, Experimental Medicine & Clinical Development, Global Patient Safety, Regulatory Affairs, Medical Documentation and Quality Operations, Medical Affairs, and Project and Portfolio Management, as well as local Drug Development hubs in the US, China, and Japan.


In R&D, you will join a community of diverse talents, united by an ambition to become number one in brain health for the service of patients, a drive to advance a pipeline of innovative therapies, and a commitment to teamwork and personal development.

More From Lundbeck


Discover our projects and compounds in development.

Restoring Brain Health

What brain health means to us at Lundbeck.

Lundbeck at a Glance

A quick look into Lundbeck’s key facts and figures.

UK-NOTPR-1945 | May 2024